HealthCare Global Enterprises Limited
Simbols: HCG.BO
BSE
360.1
INRTirgus cena šodien
142.5224
P/E koeficients
-2.9066
PEG koeficients
50.16B
MRK Cap
- 0.00%
DIV ienesīgums
HealthCare Global Enterprises Limited (HCG-BO) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1746.2 | 2041.5 | 1657.3 | |||||||||
balance-sheet.row.short-term-investments | 0 | 292.3 | 66.4 | 1357.3 | |||||||||
balance-sheet.row.net-receivables | 0 | 3095.5 | 2428.1 | 2148 | |||||||||
balance-sheet.row.inventory | 0 | 382.9 | 299.7 | 211.1 | |||||||||
balance-sheet.row.other-current-assets | 0 | 339.2 | 216.8 | 224.7 | |||||||||
balance-sheet.row.total-current-assets | 0 | 5803.4 | 5023.4 | 4349.6 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 13712.7 | 13577.9 | 12945.6 | |||||||||
balance-sheet.row.goodwill | 0 | 1812.3 | 1812.7 | 963.4 | |||||||||
balance-sheet.row.intangible-assets | 0 | 186.7 | 298 | 214.9 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1999.1 | 2110.7 | 1178.3 | |||||||||
balance-sheet.row.long-term-investments | 0 | 248 | 257.3 | 875.9 | |||||||||
balance-sheet.row.tax-assets | 0 | 52.7 | 59.6 | 343.1 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 1344.3 | 1166.4 | 663.6 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 17356.8 | 17171.9 | 16006.5 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 23160.2 | 22195.2 | 20356.1 | |||||||||
balance-sheet.row.account-payables | 0 | 2484.5 | 1939.4 | 1455.2 | |||||||||
balance-sheet.row.short-term-debt | 0 | 864 | 859 | 1624.2 | |||||||||
balance-sheet.row.tax-payables | 0 | 24.7 | 5.3 | 3.5 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 8148 | 8287.8 | 8154.9 | |||||||||
Deferred Revenue Non Current | 0 | 359.3 | 255 | 279.8 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 2113.2 | 1604.6 | 1351.8 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 8762.8 | 8660.6 | 8563.7 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 5018.6 | 5070.4 | 5058.2 | |||||||||
balance-sheet.row.total-liab | 0 | 14466 | 13358.1 | 13216.1 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 1391.2 | 1390.1 | 1253.6 | |||||||||
balance-sheet.row.retained-earnings | 0 | -4522.4 | -4365.5 | -4751 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 13040 | 13019.1 | 11228.1 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -1303.5 | -1340.9 | -758.9 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 8605.2 | 8702.9 | 6971.8 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 23160.2 | 22195.2 | 20356.1 | |||||||||
balance-sheet.row.minority-interest | 0 | 88.9 | 134.3 | 168.2 | |||||||||
balance-sheet.row.total-equity | 0 | 8694.2 | 8837.1 | 7140 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 226.6 | 249.5 | 388.5 | |||||||||
balance-sheet.row.total-debt | 0 | 9012 | 9146.8 | 9779 | |||||||||
balance-sheet.row.net-debt | 0 | 7265.8 | 7171.7 | 9479 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 448.8 | 877.7 | -2286.6 | |||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1634.7 | 1582.8 | 1592.2 | |||||||||
cash-flows.row.deferred-income-tax | 0 | -33.5 | -65.9 | 486.5 | |||||||||
cash-flows.row.stock-based-compensation | 0 | 65.1 | 31 | 19.1 | |||||||||
cash-flows.row.change-in-working-capital | 0 | -458.7 | -105.2 | -507.1 | |||||||||
cash-flows.row.account-receivables | 0 | -785.5 | -404.4 | -78.5 | |||||||||
cash-flows.row.inventory | 0 | -83.1 | -60.8 | 21.5 | |||||||||
cash-flows.row.account-payables | 0 | 563.5 | 442.9 | -528.9 | |||||||||
cash-flows.row.other-working-capital | 0 | -153.5 | -83 | 78.8 | |||||||||
cash-flows.row.other-non-cash-items | 0 | 859.4 | -119.3 | 1901.2 | |||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -1332.4 | -712.3 | -354.2 | |||||||||
cash-flows.row.acquisitions-net | 0 | 55.6 | 379.9 | -52.5 | |||||||||
cash-flows.row.purchases-of-investments | 0 | -634.1 | -824 | -2883.6 | |||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 501.9 | 2278 | 1515.8 | |||||||||
cash-flows.row.other-investing-activites | 0 | 78.6 | 124.3 | 63.5 | |||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -1330.3 | 1245.9 | -1711 | |||||||||
cash-flows.row.debt-repayment | 0 | -627.6 | -3455.6 | -2631.7 | |||||||||
cash-flows.row.common-stock-issued | 0 | 8.9 | 1321.6 | 5194.4 | |||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.other-financing-activites | 0 | -782 | 585.1 | -1440.2 | |||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -1400.7 | -1548.8 | 1122.4 | |||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.net-change-in-cash | 0 | -215.1 | 1898.3 | 616.6 | |||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1711.8 | 1926.9 | 28.6 | |||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1926.9 | 28.6 | -587.9 | |||||||||
cash-flows.row.operating-cash-flow | 0 | 2515.9 | 2201.2 | 1205.2 | |||||||||
cash-flows.row.capital-expenditure | 0 | -1332.4 | -712.3 | -354.2 | |||||||||
cash-flows.row.free-cash-flow | 0 | 1183.5 | 1488.9 | 851 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 16760.5 | 13831.4 | 10040.1 | |||||||||
income-statement-row.row.cost-of-revenue | 0 | 7997.6 | 6820.7 | 4998.5 | |||||||||
income-statement-row.row.gross-profit | 0 | 8762.9 | 7010.6 | 5041.6 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.other-expenses | 0 | 6.1 | 5 | 11.9 | |||||||||
income-statement-row.row.operating-expenses | 0 | 7109.6 | 6236.2 | 5367.4 | |||||||||
income-statement-row.row.cost-and-expenses | 0 | 15107.2 | 13056.9 | 10366 | |||||||||
income-statement-row.row.interest-income | 0 | 118.1 | 115.6 | 156.1 | |||||||||
income-statement-row.row.interest-expense | 0 | 914.7 | 838.9 | 1103 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -1299.4 | -6.4 | -2017.2 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | 0 | 6.1 | 5 | 11.9 | |||||||||
income-statement-row.row.total-operating-expenses | 0 | -1299.4 | -6.4 | -2017.2 | |||||||||
income-statement-row.row.interest-expense | 0 | 914.7 | 838.9 | 1103 | |||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1634.7 | 1582.8 | 1592.2 | |||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||
income-statement-row.row.operating-income | 0 | 1653.2 | 788.4 | -368.4 | |||||||||
income-statement-row.row.income-before-tax | 0 | 448.8 | 877.7 | -2286.6 | |||||||||
income-statement-row.row.income-tax-expense | 0 | 272.5 | 488.5 | -75.6 | |||||||||
income-statement-row.row.net-income | 0 | 293.5 | 537.3 | -1934.6 |
Biežāk uzdotie jautājumi
Kas ir HealthCare Global Enterprises Limited (HCG.BO) kopējie aktīvi?
HealthCare Global Enterprises Limited (HCG.BO) kopējie aktīvi ir 23160170000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir N/A.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.517.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir 2.531.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 0.019.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir 0.076.
Kāda ir HealthCare Global Enterprises Limited (HCG.BO) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir 293490000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 9011980000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 7109640000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 0.000.